Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

stem cell research

stem cell research

3 results

Filter Results By

Filter Applied. Clear All

Latest Posts

April 22, 2024 A Fact-Free Campaign Against Parents and Unborn Children in Alabama A Fact-Free Campaign Against Parents and Unborn Children in Alabama April 17, 2024 Fact Sheet: Planned Parenthood’s 2022-23 Annual Report Fact Sheet: Planned Parenthood’s 2022-23 Annual Report April 10, 2024 New Study: Abortion Increases Risk of Cardiovascular Diseases New Study: Abortion Increases Risk of Cardiovascular Diseases
Reset All Filters
3 results
stem cell research

Grants for Stem Cell Research Favor Ethical Approaches

The Maryland Stem Cell Research Fund (MSCRF) has awarded two rounds of grants since the Charlotte Lozier Institute last analyzed the Fund’s pattern of grant making for stem cell research, in the fall of 2013. That study found that since MSCRF first began awarding grants in 2007, its pattern of giving shifted over the years from strongly favoring projects focusing on ethically contentious human embryonic stem cell research (hESCR) to projects focusing on ethically non-contentious adult stem cells and other non-embryonic stem cell research.

Eugene C. Tarne
October 10, 2016
ClosePlease login
stem cell research

iPSCs: A New Gold Standard in Regenerative Medicine?

A recent press release from the National Institutes of Health calls attention to a study, published in Stem Cell Reports, that researchers have “developed a clinical-grade stem cell line, which has the potential to accelerate the advance of new medical applications and cell-based therapies for millions of people suffering from such ailments as Alzheimer's disease, Parkinson's disease, spinal cord injury, diabetes, and muscular dystrophy.”

featured-image
stem cell research

Written Testimony of David A. Prentice, Ph.D.: Update on Progress of Kansas’ Midwest Stem Cell Therapy Center Research

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image